Li Kang Biomedical Co Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Li Kang Biomedical Co Ltd

Watchlist Manager

Watchlist

Price: 33.85 TWD Market Closed

Market Cap: NT$1.1B

L	Li Kang Biomedical Co Ltd TPEX:6242	TW
A	Antec Inc TPEX:6276	TW

Profitability Summary

Li Kang Biomedical Co Ltd's profitability score is 48/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

67%

Strong 3Y Average Gross Margin

55%

Gross Margin is Increasing

66% > 67%

Healthy Operating Margin

15%

Sustainable 3Y Average Operating Margin

17%

Declining Operating Margin

21% > 15%

Healthy Net Margin

13%

Sustainable 3Y Average Net Margin

13%

Declining Net Margin

18% > 13%

Negative Free Cash Flow Margin

-135%

Negative 3Y Average Free Cash Flow Margin

-9%

Declining Free Cash Flow Margin

15% > -135%

Low ROE

Exceptional 3Y Average ROE

Exceptional 3Y Average ROIC

48%

Declining ROIC

24% > 0%

View All

Hide

Collapse

48 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.